10 th Annual Conference on

Hepatology & Hepatitis

Theme: Noval Therapy for Liver and Pancreatric Diseases

Event Date & Time

Event Location

Lisbon, Portugal

18 years of lifescience communication

442382029256

Previous Conference Performers / Professionals From Around The Globe

Conference Speaker

Shunlin Ren

Virginia Commonwealth University-McGuire VA Medical Centre,
USA

Conference Speaker

Gerald C Hsu

Eclaire MD Foundation,
USA

Conference Speaker

Hani Oweira

Hirslanden Private Hospital Group,
Swaziland

Conference Speaker

Grzegorz Onik

Medical University of Silesia
Poland

Conference Speaker

Mac Martin

CHU Brugmann, OSIRIS Biotechnical Group, Brussels,
Belgium

Conference Speaker

Dimitri Mikhalski

CHU Erasme, Free Brussels University (ULB), Brussels
Belgium

Conference Speaker

Tarek E Korah

Menoufiya University
Egypt

Conference Speaker

Khaled Elshaar

King Fahd Central Hospital, Saudi Arabia
Saudi Arabia

Conference Speaker

M Fathy Ghaffar

Ain Shams University
Egypt

Conference Speaker

YAZAN ABU QWAIDER

Texas Tech University Health Sciences Center
USA

Conference Speaker

NADA ALAAEDDINE

University of Montreal Canada
Canada

Conference Speaker

VLADIMIR MALKOV

Saint Petersburg University Clinic of High Medical Technologies
Russia

Tracks & Key Topics

Hepatology 2019

ABOUT CONFERENCE

EuroSciCon the World Class Scientific Event Organizer is pleased to have "Annual Conference on Hepatology and Hepatitis" amid July 29-30, 2019 in Lisbon, Portugal. This Gastro meeting features the subject "Late progressions and remedial procedures in the field of Gastroenterology Hepatologylogy ".

Hepatology 2019 primarily concentrates on the most recent analytic and restorative methods for hepatic diseases. This gastro gathering talks about the most recent research results and innovative progressions in the field and unites driving hepatologists, gastroenterologists, specialists, doctors, investigate researchers, understudies alongside mechanical and pharma experts to trade share their perspectives on basic parts of gastroenterology inquire about. This hepatology meeting unites Presidents and Eminent Personalities to investigate openings on developing stages in the field of gastrointestinal therapeutics. With individuals from around the globe concentrated on finding out about most recent analytic and treatment systems of different gastrointestinal sicknesses and all the related parts of gastrointestinal ailments, this is your best chance to achieve the biggest collection of members from the whole world. From the workshop and discourse in this hepatology gathering from the famous individuals of Hepatology, you can refresh your insight about the current circumstance of hepatology and get name and acknowledgment at this 2-day occasion. Hepatology meeting will give the stage to share thoughts. Incredibly famous speakers with their definitive chats on the latest methods, strategies, and the vanguard advancements in hepatology therapeutics are the signs of this meeting

Market Analysis report 

Hepatology deals with the study, prevention, diagnosis and management of diseases that affect the liver, gallbladder, biliary tree and pancreas. The therapy of liver diseases has a growing importance as the number of patients in need is still rising.Hepatitis is an inflammatory condition of the liver caused by the hepatitis virus. The most observed form of this disease is hepatitis A, hepatitis B, and hepatitis C. More than 1 million people die each year from causes related to viral hepatitis, commonly cirrhosis, and liver cancer. According to WHO nearly 500 million people have chronic viral hepatitis worldwide. Approximately 1 in 12 persons worldwide are living with chronic viral hepatitis. Presently, an estimated 5.5 million Americans suffer from the chronic liver disease. One of the top most leading causes of death of liver diseases is due to the combined diagnoses of chronic liver disease, cirrhosis, viral hepatitis and liver cancer.

Hepatology medicine is on the threshold of massive changes. Vaccination programs can help but still, the mortality rate due to Liver diseases is increasing day by day and it is stated as a complicated one. Worldwide therapy of the consequences of viral hepatitis for the liver is available only for a minority. Access to innovative treatment of liver cancer and its therapy is limited here.

Sessions:

About The Subject

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas as well as management of their disorders. Although traditionally considered a sub-specialty of gastroenterology, rapid expansion has led in some countries to doctors specializing solely on this area, who are called hepatologists.

The field of liver disease. The liver is the body's largest organ and hepatology is a large field. It includes, but is not limited to, the study of acute and chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, liver transplantation, drug metabolism (which depends largely upon the liver), and immunology as it pertains to the liver.

Gastroenterology is the branch of medicine focused on the digestive system and its disorders.

Diseases affecting the gastrointestinal tract, which include the organs from mouth to anus, along with the alimentary canal, are the focus of this specialty.

Who can Attend?

The main aim of this conference is to gather HepatologistsGastroenterologistsPathologists, Directors/CEO & Industry experts, Professors, Researchers, Scientists and Students dealing in all areas of Hepatology and Gastroenterology & Therapeutics and to provide an international forum for the dissemination of original research results, new ideas and practical development experiences related to the research.

Opportunities for Conference Attendees

For Researchers &Faculty:

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing
  • For Universities, Associations & Societies:
  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients

 

ABOUT SESSION

TRACKS AND SESSIONS

Hepatology

 

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas function as well as management of their disorders. The study of these organ deals with the understanding of clinical syndrome of non-cirrhotic portal hypertension and Congenital Hepatic Fibrosis; study the biological processes underlying the development of hepatic regeneration and study aspects of viral hepatitis that allow insight into disease mechanisms.

Session Keywords:

Hepatitis: Care and Cure

Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus (HCV) infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis.

Session Keywords:

Liver Diseases

Diagnosing Liver Di Liver diseases are caused by metabolic, genetic drug induced and due to autoimmune diseases. Hepatic coma also known as Hepatic encephalopathy is a metabolic abnormality caused by accumulation of toxic substances in the bloodstream that are normally removed by the liver. Haemochromatosis is a genetic disorder caused by accumulation of iron in the liver. Non-alcoholic fatty liver disease is a drug induced liver disease caused by accumulation of extra fat in liver cells that is not caused by alcohol, whereas Alcoholic liver disease is due to overconsumption of alcohol. Primary biliary cirrhosis is an autoimmune disease of the liver in which the bile ducts in liver are slowly destroyed.

Session Keywords:

Hepatocellular Carcinoma and Pancreatic Cancer

Hepatocellular carcinoma accounts for most liver cancers. This type of liver cancer occurs more often in men than women and is usually seen in people age 50 or older. It is commonly associated with cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of hepatocellular carcinoma. Other risk factors can include a history of alcohol abuse.

Session Keywords:

Clinical Liver Transplantation and Liver Surgery

Liver transplantation is the only treatment possible option for end-stage liver disease and acute liver failureResearch is going on development of artificial liver support, a technology based on artificial materials for partial replacement of liver function. Liver surgery comprises various operations of the liver for different disorders. The most common operation performed on the liver is a resection (removal of a portion of the liver).

Session Keywords:

Viral and Non-viral Hepatitis

Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis

Session Keywords:

Drug Discovery for Treatment of Hepatitis

In recent years, tremendous research advances are transforming treatment of Hepatitis. More than 90% of patients with the most common form of the disease can expect to be cured in as little as 8 weeks with newly approved antiviral therapies. More new medicines are on the way. Most of this progress has occurred in just the last three years with newer and more effective therapies transforming the trajectory of the disease for many patients. The scientific advances made in recent years by biopharmaceutical researchers as they combat the hepatitis C virus have already begun to have a tangible impact on thousands of patient.

Session Keywords:

Viral Hepatitis B and C

Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.

Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

Session Keywords:

Liver Inflammation and Immunology

Liver inflammation is a response that happens when liver cells are assaulted by a sickness bringing on microorganism or substance. The word hepatitis alludes to liver inflammation. Most types of hepatitis result from viral disease, despite the fact that now and again it is brought on by an immune system issue, in which the body's safe framework assaults liver cells since it can't differentiate between unsafe trespassers and solid liver tissue. Harm to the liver from liquor, toxins, and certain medications can likewise bring about inflammation. Liver Immunology implies the special connection between the liver and the immune system. Livers hose down immunity to such a degree, to the point that they can be transplanted without dismissal sometimes. Livers may be endured, as well as keep the dismissal of other organ unites from a similar benefactor, a procedure known as immune tolerance.

Session Keywords:

Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Session Keywords:

Liver Failure

Liver failure also called as hepatic insufficiency is a severe deterioration in liver function. It is mainly caused by a disorder or substance that damages the liver. Hepatic failure can either be acute or chronic. Symptoms of hepatic failure include nausea , jaundice, bruising or bleeding easily, edema or fluid buildup in the legs, a loss of appetite and fatigue. Treatment generally involves limiting sodium in the diet, controlling protein consumption, completely avoiding alcohol, and treating the cause, but sometimes liver transplantation is required

Session Keywords:

Hepatic encephalopathy

Hepatic encephalopathy may be an syndrome watched over patients for cirrhosis. Hepatic encephalopathy will be characterized similarly as a range about neuropsychiatric abnormalities in patients for liver dysfunction, then afterward prohibition from claiming mind ailment. Hepatic encephalopathy is described eventually as customized changes, scholarly impairment, also a discouraged level of cognizance.

Hepatic encephalopathy may be additionally portrayed in patients without cirrhosis for Possibly spontaneous alternately surgically made portosystemic shunts. The improvement about hepatic encephalopathy is explained, will a few extent, toward the impact of neurotoxic substances, which happens in the setting from claiming cirrhosis What's more portal hypertension.

Session Keywords:

Hepatic Fibrosis

Hepatic fibrosis will be excessively overflowing wound recuperating clinched alongside which over the top connective tissue assembles up in the liver. Those extracellular grid may be overproduced, corrupted deficiently, or both. Those trigger will be unending injury, particularly if there may be an incendiary part. Fibrosis itself reasons no indications Be that camwood prompt portal hypertension (the scarring distorts bloodstream through the liver) alternately cirrhosis u (the scarring brings about disturbance from claiming ordinary hepatic construction modelling Furthermore liver dysfunction). The analysis is in light of liver biopsy. Medication includes correcting those underlying condition The point when could be allowed.

Session Keywords:

Lupoid Hepatitis

Lupoid hepatitis may be an incessant or enduring infection for which the body's safe framework strike those typical components, or cells, of the liver Furthermore makes aggravation and liver harm. The immune system normally protects people from infection by identifying and destroying bacteria, viruses, and other potentially harmful foreign substances.  Lupoid hepatitis is a genuine condition that might compound about whether though not treated. Immune system hepatitis might prompt cirrhosis also liver disappointment. Cirrhosis happens the point when scar tissue replaces sound liver tissue What's more obstructs the ordinary stream of blood through those liver. Liver disappointment happens when the liver stops attempting legitimately.

Session Keywords:

Primary Sclerosing Cholangitis

Primary sclerosing cholangitis (PSC) will be a chronic, alternately long-term, infection that gradually harms the bile ducts. Bile may be a digestive fluid that is committed in the liver. It sets out through the bile ducts of the gallbladder and the little intestine, the place it aides digest fats What's more greasy vitamins.

Clinched alongside patients with PSC, the bile ducts turn into blocked because of aggravation also scarring or fibrosis. This makes bile on gather in the liver, the place it bit by bit harms liver phones Also reasons cirrhosis, alternately fibrosis of the liver. Likewise, cirrhosis progresses and the measure from claiming scar tissue in the liver increases, those liver gradually loses its capability will capacity. The scar tissue might piece waste of the bile ducts prompting contamination of the bile.

Session Keywords:

Hepatitis Prevention

The greater part as a relatable point routes from claiming transmission for hepatitis infections are

Blood transfusions Also blood results utilizing unscreened blood (in the vast majority created nations blood need been screened since regarding 1990). Medicinal or dental intercessions without sufficient disinfection for supplies. Mothball will baby throughout labour (very basic for hepatitis B; Lesquerella as a relatable point Previously, hepatitis C). Needle stick harm done social insurance settings. Imparting gear for injecting pills. Offering razors, toothbrushes alternately other family articles. Tattooing Also muscle to piercing if finished utilizing  unsterilized supplies. On account from claiming hepatitis B, contamination camwood also happen through Hosting unprotected sex for a contaminated man.

Though you believe you Might need been toward danger starting with Possibly hepatitis B or C, it may be essential on get tried. A particular test may be needed to every.

Session Keywords:

Hepatitis Cancer

People who would contaminated with hepatitis b infection (HBV) or hepatitis c (HCV) infection might create An incessant contamination that could prompt cirque. Those harm that outcomes expands those hazard about liver tumor (hepatocellular carcinoma). The danger for liver tumor may be more excellent to individuals who have incessant HBV or HCV spoiling over for the all number.

Though you have unending HBV infection:

  • You might create liver tumor regardless of you don't need cirque. Be that as a large portion kin who have HBV and liver tumor also have cirrhosis.
  • Accepting antiviral treatment will treat incessant HBV contamination might more level your danger for creating liver tumor.
  • On you bring incessant HCV infection:
  • Those strain (genotype) for HCV spoiling doesn't show up should influence your hazard for Creating liver tumor.
  • You would not at critical hazard for Creating tumor unless you also as of now have cirrhosis.
  • You need aid during extraordinarily expanded danger for liver tumor In you need alcohol-related cirque What's more will hepatitis.
  • Getting antiviral treatment will treat unending HCV spoiling might easier your hazard to Creating liver tumor. 2
  • Screening with ultrasonography of the liver, liver work tests, What's more blood tests (counting alpha-fetoprotein [AFP]) each 6 on 12 months will be proposed to people in danger about liver tumor.

Session Keywords:

Gene Expression on hepatitis

The later advancement of effective instruments to extensive scale dissection from claiming gene interpretation need gave new insights under the part of gene networks and administrative pathways Previously, Different tumor forms. These instruments incorporate microarrays, which could investigate those statement of many genes during particular case time, Furthermore ongoing reverse transcription-PCR (RT-PCR) assays to additional exact Furthermore quantitative statement dissection for more diminutive numbers about hopeful genes.

Little may be known something like those sub-atomic components connected with HCV contamination for people. Liver gene interpretation might have been studied, toward vast scale ongoing RT-PCR, On patients with untreated unending hepatitis c and gentle fibrosis compared for histologically typical controls.

Session Keywords:

Pancreatitis

  •  Pancreatitis will be a state portrayed by aggravation of the pancreas.
  • The pancreas may be an abdominal organ arranged behind the stomach in the upper abdomen.
  • Those fundamental  work of the pancreas may be to discharge hormones What's more proteins that assistance for assimilation What's more control glucose (glucose) digestion system. Those digestive proteins are discharged through the pancreatic pipe under  those small digestive system the place they would actuated with assistance break down fats and proteins.
  • Those digestive hormones (insulin Furthermore glucagon) handled Eventually Tom's perusing the pancreas need aid discharged under the blood stream the place they help control glucose levels.
  • Pancreatitis is sorted Concerning illustration continuously  whichever  intense or incessant. Intense pancreatitis by and large develops suddenly, Furthermore it is normally a short-term (a few days to weeks) disease that commonly determines with proper restorative administration.

Session Keywords:

Diagnosis of hepatitis

Finding from claiming viral hepatitis will be In view of side effects What's more physical discoveries and in addition blood tests for liver enzymes, viral antibodies, Furthermore viral hereditary materials. Analysis from claiming intense viral hepatitis regularly will be easy, yet all the analysis from claiming constant hepatitis might be troublesome. When a tolerant reports indications of fatigue, nausea, abdominal pain, obscuring of urine, et cetera develops jaundice, those finding from claiming intense viral hepatitis is prone Furthermore might make affirmed by blood tests. On the different hand, patients for Ceaseless hepatitis because of HBV Also HCV regularly need no side effects alternately best gentle nonspecific side effects for example, incessant weakness. Typically, these patients don't bring jaundice until the liver harm is distant propelled. Therefore, these patients could remain undiagnosed for a long time on decades.

Session Keywords:

MR Elastography

Those fundamental clinical implication to liver elastography will be fibrosis arranging about unending liver infection (eg, unending viral hepatitis and screening patients for NAFLD should discount non alcoholic steatohepatitis), with An principle target of figuring out the vicinity or nonattendance for propelled fibrosis. Likewise said previously, figuring out the vicinity about cirque may be important, since this will trigger screening or following methods What's more create necessity to treatment. Different signs to liver elastography incorporate catch up from claiming formerly diagnosed fibrosis, evaluation of patients with referred to cirrhosis (by Creating if there may be clinically critical portal hypertension), What's more assessment about patients with unexplained portal hypertension. For new medicines that could really diminish fibrosis over patients with viral hepatitis, an additional implication may be catch up with assess light of medication and possibly to tailor further catch up and treatment.

Session Keywords:

Hepatopancreatobiliary

HPB stands to Hepato-Pancreatico-Biliary surgery - significance surgery of the liver, pancreas Furthermore biliary framework. HPB surgeons assistance on diagnose What's more treat patients with states for example, such that liver tumor (primary alternately secondary), pancreatic cancer, pancreatitis, bile conduit cancellous also gallstones.

Bariatric Surgery

Bariatric surgery (weight reduction surgery) incorporates an assortment of methods performed on individuals who have heftiness. Weight reduction is accomplished by decreasing the measure of the stomach with a gastric band or through evacuation of a part of the stomach (sleeve gastrectomy or biliary pancreatic preoccupation with duodenal switch) or by resecting and re-directing the small digestive system to a little stomach pocket (gastric sidestep surgery).

 

This mind boggling activity is named biliary pancreatic redirection (BPD). The first type of this method is presently once in a while performed due to issues with malnourishment. It has been supplanted with a change known as duodenal switch (BPD/DS). Some portion of the stomach is resected, making a littler stomach (however the patient can eat a free eating regimen as there is no prohibitive part). The distal piece of the small digestive system is then associated with the pocket, bypassing the duodenum and jejunum.

 

In around 2% of patients there is extreme malabsorption and dietary inadequacy that requires reclamation of the ordinary retention. The malabsorptive impact of BPD is potent to the point that, as in most prohibitive techniques, the individuals who experience the method must take vitamin and dietary minerals well beyond that of the typical populace. Without these supplements, there is danger of genuine lack ailments, for example, pallor and osteoporosis.

 

ABOUT CITY

Lisbon is the capital and the largest city of Portugal, with an estimated population of 552,700within its administrative limits in an area of 100.05 km². Its urban area extends beyond the city's administrative limits with a population of around 2.7 million people, being the 11th-most populous urban area in the European Union. About 3 million people live in the Lisbon Metropolitan Area (which represents approximately 27% of the country's population). It is continental Europe's westernmost capital city and the only one along the Atlantic coast. Lisbon lies in the western Iberian Peninsula on the Atlantic Ocean and the River Tagus. The westernmost areas of its metro area form the westernmost point of Continental Europe, which is known as Cabo da Roca, located in the Sintra Mountains.
 
Tourist Attraction:
Lisbon, the capital of Portugal, is one of Europe's most beautiful and cosmopolitan cities. Set over a series of hills near the mouth of the River Tagus, it's a place inextricably linked with the sea. Intrepid navigators embarked from here in the 15th and 16th centuries to sail unknown waters and chart new lands, and the legacy of this golden Age of Discovery underpins much of the city's culture and heritage.
 
Lisbon is a colorful and vibrant destination. Renowned for its warm and sunny disposition, the city is blessed with a wealth of historic monuments, world-class museums, and a host of other fabulous things to do. You can explore the narrow streets of the old quarter, stroll the riverbank promenade, or wander through verdant parks and gardens. In fact, enjoy Lisbon like the locals do, at an easy and unhurried pace, and you'll quickly fall for its welcoming character and beguiling charm
 
Atmosphere:
Lisbon has a subtropical Mediterranean climate with mild, rainy winters and warm summers. The average annual temperature is 21.3 °C (70.3 °F) during the day and 13.5 °C (56.3 °F) at night. In the coldest month – January – the highest temperature during the day typically ranges from 10 to 18 °C (50 to 64 °F), the lowest temperature at night ranges from 3 to 13 °C (37 to 55 °F) and the average sea temperature is 16 °C (61 °F).

PAST CONFERENCE REPORT

Hepatology and Hepatitis: Past Conference Information

Hepatology & Hepatitis 2018 Report:

EuroSciCon takes a great pride in announcing the success of “Hepatology & Hepatitis 2018 which was held in Paris, France, November 12-13 2018.

Hepatology 2018 witnessed a combination of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled issues related to the field of Nursing. The extremely illustrious conference hosted by EuroSciCon was marked with the attendance of young and brilliant researchers, delegates and talented student communities representing their countries around the world.

For Hepatology 2018 Final Program: Click here

The conference aimed with a theme “Hepatology and Hepatitis 2018”. The summit engrossed a vicinity of sensible discussions on subjects like Nursing Primary CareHepatology | Hepatitis: Care and Cure| Liver Diseases | Hepatocellular Carcinoma and Pancreatic Cancer| Clinical Liver Transplantation and Liver Surgery |Viral and Non-viral Hepatitis| Drug Discovery for Treatment of Hepatitis | Viral Hepatitis B and C| Pancreatic Surgery.

The two days event implanted a firm relation of upcoming strategies in the field of Hepatology with the scientific community. The conceptual and valid knowledge shared, will also raise organizational collaborations to develop scientific accelerations.

 

Organizing Committee Hepatology 2018:

| Gerald C Hsu, Eclaire MD Foundation, USA | Grzegorz Onik, Medical University of Silesia, Poland |Dimitri Mikhalski, Katholieke Universiteit Leuven (KUL), Belgium| Marc Martin, CHU- Brugmann, Belgium| Tarek E Korah, Menoufia University, Egypt| Shunlin Ren, Virginia common-wealth University, USA| Hani Oweira, Hirslanden Hospital Group, Switzerland | 

The Organizing Committee would like to thank the moderator Grzegorz Onik, Poland for his support which resulted in smooth functioning of the conference.

The conference was boarded with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum.

The best Part of the conference was the keynote forum by prominent scientists: Gerald C HsuEclaire MD Foundation, USA,  | Shunlin Ren, Virginia common-wealth University, USA | Hani Oweira, Hirslanden Hospital Group, Switzerland | gave their profitable contributions in the form of highly enlightening presentations and made the conference a best notch one.

EuroSciCon Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chair and Co-chairs on engrossing the keynote sessions, workshops, Symposiums and YRF and Poster sessions in an expanded manner to make this conference a privileged Summit.

Hepatology2018 Speaker Line Up:

Day 1

Speakers:

| Gerald C Hsu, Eclaire MD Foundation, USA | Grzegorz Onik, Medical University of Silesia, Poland |Dimitri Mikhalski, Katholieke Universiteit Leuven (KUL), Belgium| Marc Martin, CHU- Brugmann, Belgium| Tarek E Korah, Menoufia University, Egypt| Shunlin Ren, Virginia common-wealth University, USA| Hani Oweira, Hirslanden Hospital Group, Switzerland |

We once again thank all the participants for their wonderful involvement towards the event which helped us for the successful execution of this event.

EuroSciCon takes a great pride in declaring the upcoming conference “10th  Annual Conference On Hepatology and Hepatitis ” (Hepatology 2019) which is going to be held at Lisbon, Portugal during July 29-30, 2019.  

 

 

MARKET ANALYSIS REPORT

Hepatology is the study, prevention, finding What's more management of ailments that influence the liver, gallbladder, biliary tree also pancreas. The treatment about liver illnesses need a developing importance Likewise those amount of patients Previously, necessity is still climbing. Hepatitis will be an incendiary condition of the liver initiated towards those hepatitis infection. The A large portion watched type about this illness may be hepatitis A, hepatitis B and hepatitis C. More than 1 million kin pass on every year from reasons identified with viral hepatitis, ordinarily cirque and liver tumor. As stated by WHOAbout 500 million people need constant viral hepatitis around the world. Roughly 1 over 12 persons around the world need aid existing with constant viral hepatitis. Presently, a assessed 5. 5 million Americans middle of the road starting with unending liver infection. A standout amongst the highest point The greater part heading foundations about demise of liver illnesses will be because of those joined together diagnoses about constant liver disease, cirrhosis, viral hepatitis and liver tumor. 
 
Hepatology medication will be on the edge of monstrous progressions. Inoculation projects might help However still the mortality because of liver ailments is expanding step by step and it may be expressed Likewise a muddled one. Around the world treatment of the results from claiming viral hepatitis for the liver will be accessible main to a minority. Get will imaginative medicine from claiming liver tumor Furthermore its treatment is set here. 
 

LEARN MORE

Recommended EuroSciCon conferences:

Chemistry Research, Dec 06-07, 2018 Netherlands | Clinical pathology , Feb 27-28, 2019 Czech Republic | Euro Gastro 2019, March 11-12, 2019 Netherlands | Dental & Dental Hygiene, March 25-26, 2019 Hungary | Data Analytics , April 08-09, 2019 France | Dermatology 2018, April 18-19, 2019 France | Microbiology and Virology, April 22-23, 2019 Greece | Infectious Diseases & Std-Aids 2019 April 15-16, 2019 France | Quantum & Plasma physics , May 09-10, 2019 Sweden | Euro Optics , May 09-11, 2019 Sweden | Advance Nursing Practice, May 23-24, 2019 Sweden | Psychiatry & Psychology , April 11-12, 2019 France | Renewable and Green Energy, March 21-22, 2019 Netherlands| Nano 2019, Oct 07-09, 2019, Japan | Advanced Energy Materials, Oct 07-09, 2019 Japan | Materials Science & Engineering, June 04-06, 2019 France | Nursing Diagnosis, July 25-26, 2019 Luxembourg |Nursing & Midwifery, May 23-24, 2019  Sweden | Nuclear Medicine & Radiation Therapy, June 10-12, 2019 Netherlands

Top Hepatology University World Wide

Europe Hepatology University:

Autonomous University of Madrid Catholic University of Valencia The Autonomous University of Barcelona | Complutense University of Madrid | International University of Catalonia | Miguel Hernandez University Pompeu Fabra University  | Rovira i Virgili University | The Universitat Oberta de Catalunya (UOC)  | The University of Barcelona (UB) | Universidad Santiago de Compostela  | University CEU San Pablo | University of AlcalaUniversity of Alicante University of Cadiz | University of Cantabria | University of Castilla-La Mancha | University of Cordoba | University of Extremadura University of Girona | University of Granada University of Jaen University of La Laguna University of Lleida University of Malaga  | University of Murcia | University of Navarra | University of Oviedo | University of Salamanca University of Seville University of Valencia | University of ValladolidUniversity of Zaragoza

USA Hepatology University:

Duke University School of Medicine | Harvard Medical School | Johns Hopkins School of Medicine  | Emory University School of Medicine Yale School of Medicine | Baylor College of Medicine | Washington University School of Medicine | Mayo Clinic College of Medicine Wayne State University School of Medicine University of Massachusetts Medical School | University of Maryland School of Medicine Johns Hopkins University School of Medicine | University of Kansas School of Medicine  | Rush Medical College | Loyola University Chicago Stritch School of Medicine Medical College of Georgia at Augusta University Florida State University College of Medicine | Howard University College of Medicine | Georgetown University School of Medicine  George Washington University Medical School 

Asia Hepatology Universities:

International University - Cambodia (IU) | University of Health Sciences - Cambodia (UHS-C) | University of Puthisastra (UP) | Akaki Tsereteli State University David Agmashenebeli University of Georgia | Tbilisi State Medical University Hashemite University Jordan University of Science and Technology | Mutah University University of Jordan Nanyang Technological University | National University of Singapore|Mordovian Ogarev State University 

Europe Hepatology Societies:

The European Section and Board of Gastroenterology and Hepatology | European Association for the Study of the Liver | World Gastroenterology Organization European Liver Patients Association | Albanian Association of Gastroenterology & Hepatology| Austrian Society of Gastroenterology & Hepatology | Byelorussian Gastroenterology Association | Royal Belgian Society of Gastroenterology | Flemish Association for Gastroenterology (VVGE) | Association of Gastroenterologists & Hepatologists of Bosnia & Herzegovina | Bulgarian Society of Gastroenterology | Croatian Society of Gastroenterology | Czech Society of Gastroenterology | Estonian Society of Gastroenterology | Finnish Society of Gastroenterology | French National Society of Gastroenterology | 

USA Hepatology Societies:

American Association for the Study of Liver Diseases (AASLD) | North American Society for Pediatric Gastroenterology, Hepatology and Nutrition | Gastroenterology & Hepatology Associates | American College of gastroenterology | American Gastroenterological Association | American Society for Gastrointestinal Endoscopy | American Hepato-Pancreato-Biliary Association | Canadian Liver Foundation | International Association for the Study of the Liver | International Hepato Pancreato Biliary Association | Hepatitis B FoundationHepatitis Foundation International | American Liver Foundation | Canadian Association of Gastroenterology | Canadian Association for the Study of the Liver | American Pancreatic Association | Associates in Gastroenterology | Canadian Liver Foundation (CLF) | Canadian Society of Gastroenterology Nurses and Associates | Massachusetts Gastroenterology AssociationMichigan Society of Gastroenterology Nurses and Associates | Mississippi Gastroenterology SocietyAmerican Society for General Surgeons | Philippine Society of General Surgeons

Asia Hepatology Societies:

The Asia-Pacific Primary Liver Cancer Expert Association | The Asian Pacific Association of Gastroenterology | Asian Pacific Association for the Study of the Liver | International Society for Digestive Surgery | Gastroenterological Society of Australia | International Society for Digestive Surgery | Taiwan Liver Cancer Association | The Korean Association for the Study of the Liver | The Asia-Pacific Primary Liver Cancer Expert Association | Australia and New Zealand Hepatic Pancreatic and Biliary Association Incorporated | 

Europe Hepatology Conferences:

Liver & Pancreatic Diseases July 29-30 2019 Lisbon, Portugal | Hepatology & Hepatitis July  29-30 2019 Lisbon, Portugal |

USA Hepatology Conferences:

11th Diabetologist Conferences May 23-24, 2018 New York USA|International Liver Conferences May 25-26, 2018 New York USA|3rd International Hepatobiliary & Pancreatic Disorder Conferences September 17-18, 2018 Philadelphia Pennsylvania|World Digestive & Metabolic Diseases ConferencesSeptember 21-22, 2018 Vancouver Canada|2nd International Clinical Diabetes, Diabetic Medication &Treatment ConferencesSeptember 27-29, 2018 Montreal Canada|International Diabetes and Diabetic Nursing Care Conferences  September 28-29, 2018 Montreal Canada

Asia Hepatology Conferences:

11th International Gastroenterologists Conferences December 14-15, 2017 JW Marriott Dubai UAE 

Hepatology Companies in Europe:

Sequana Medical | Versantis AG | CYP Design | Promethera Biosciences | Wilson TherapeuticsDefiniGEN | Biotie Therapies | iQur (formerly HepCgen) | DLiver AS | Humedics | Cytonet | Ildana Biotech | CAScination AG | MDW | CMC Contrast | Organox | HepaRegeniX | Enterome Bioscience | ACC | Perspectum Diagnostics

Hepatology Companies in USA:

Proteostasis Therapeutics | Ocera Therapeutics | Virobay | Conatus Pharmaceuticals | Perspectum Diagnostics Ltd | Intercept Pharmaceuticals | Cholestech Corporation | HepQuant | New York Huaqi Bioengineering, LLC | Qualiber | Assembly Biosciences | Enanta Pharmaceuticals|FibroGen | Albireo Pharma | Arbutus Biopharma Corporation | Arrowhead Research Corporation | Dicerna Pharmaceuticals | Dimension Therapeutics | Madrigal Pharmaceuticals | Ocera Therapeutics | Phaserx | Vital Therapies

Hepatology Companies in Asia:

Galmed Pharmaceuticals Ltd | Biostar Pharmaceuticals | Raptor Pharmaceuticals |Genfit  | Livac Pvt Ltd Verva PharmaceuticalsHepatera | Dimension Therapeutics | ZS Pharma | Pharma corporation of India | Eskag pharma private limited | Nexus drugs private limited | Medley Pharmaceuticals Limited | Zambon India Private Limited | Pfiscar India limited | Schwitz Biotech | Bravo Healthcare Limited | Spb Pharma | Enal Drugs Private Limited | Merit Organics Limited | Health India Laboratories | Olita Scientific Works | Zota Pharmaceuticals Private Limited | Flamingo Pharmaceuticals Limited | Nosch Labs Private Limited | Pelcoat formulations

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!